Fast Facts
#3
in NIH Funding
Top Ranked
consistently ranked a top tier residency program
30+
active clinical trials
Neurosurgery News & Innovations
Comprehensive patient care
National leaders in every subspecialty offer personalized, team-based care for the full range of adult and pediatric neurosurgical conditions.
Showing: All results

Commitment to innovation
Our rare focus on innovation and technology allows us to offer patients the very latest advances and optimal treatments — many developed by our own highly skilled surgeons.

Need to make an appointment?
Offering in-person visits at nine convenient locations.
Excellence in education
Our seven-year residency and one-year fellowship prepare trainees for successful careers in academic neurosurgery.
- Mentorship from pioneers in the field
- Extraordinary research opportunities
- High-volume, comprehensive clinical practice
- Collaborative, all-encompassing culture

News
Dacey receives the BJH Lifetime Achievement Award
On Nov. 14, 2024, Ralph G. Dacey, Jr., MD was honored for his thirty years of service to Barnes-Jewish Hospital and was awarded the BJH Lifetime Achievement “Master Physician” Award. Dr. Dacey was introduced by Chief of the Division of Spine Surgery Dr. Wilson Zachary Ray. To his peers, Dr. Dacey was regarded as one […]
Researchers define new subtypes of common brain disorder
Using artificial intelligence, WashU Medicine researchers from neurosurgery and computer science have identified 3 subtypes of Chiari type-1 malformations that could improve medical decision making By: Mark Reynolds Roughly 4% of the population is affected by a congenital brain malformation that has eluded researchers’ efforts to find causes and treatments. For the condition, Chiari type-1 […]
Researchers make glioblastoma cells visible to attacking immune cells
Strategy involves placing targets on deadly cancer’s cells, potentially making them vulnerable to immunotherapies By: Julia Evangelou Strait Even treated with the most advanced therapies, patients with glioblastoma — an aggressive brain cancer — typically survive less than two years after diagnosis. Efforts to treat this cancer with the latest immunotherapies have been unsuccessful, likely […]













